The Wyss DxA is Harvard’s Wyss Institute’s initiative to create and deliver disruptive diagnostic technologies to address unmet clinical needs in the screening, diagnosis, prognosis, and management of diseases. Through its participation in the Industrial Participant Program, Fluxergy plans to collaborate with distinguished clinicians, researchers, engineers, funding agencies, philanthropists, government agencies, and industry partners.
(PRWeb May 12, 2022)
Read the full story at https://www.prweb.com/releases/2022/05/prweb18668658.htm
For more information, please visit
https://www.prweb.com/releases/2022/05/prweb18668658.htm